AsianFin -- Elon Musk’s brain-chip startup Neuralink is aiming to generate at least $1 billion in annual revenue by 2031, with plans to implant its device in 20,000 people each year, Bloomberg News reported Wednesday, citing investor materials.

The company intends to open five large-scale clinics within six years and roll out three product lines: Telepathy for brain-to-device communication, Blindsight to restore vision, and Deep to treat neurological disorders such as tremors and Parkinson’s disease, the report said.